Characterization of serum-free ex vivo-expanded hematopoietic stem cells derived from human umbilical cord blood CD133+ cells

Stem Cells and Development

Volumn 15, Issue 1, 2006, Pages 70-78

  Yao, Chao Ling ^a   Feng, Yin Hsun ^b   Lin, Xi Zhang ^b   Chu, I Ming ^c   Hsieh, Tzu Bou ^a   Hwang, Shiaw Min ^a  

^a FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; TELOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BATCH CELL CULTURE; BONE MARROW; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; EX VIVO STUDY; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; LETHALITY; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SERUM; TELOMERE; UMBILICAL CORD BLOOD;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; BONE MARROW; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL SEPARATION; CELLS, CULTURED; CYTOKINES; FETAL BLOOD; GLYCOPROTEINS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, SCID; PEPTIDES; STEM CELLS; TELOMERASE; TELOMERE;

ANIMALIA;

EID: 33645417001     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.15.70     Document Type: Article

References (41)

1. Gluckman E, V Rocha and C Chastang. (1998). Cord blood banking and transplant in Europe. Bone Marrow Transplant 22:68-74.
2. Gluckman E. (2000). Current status of umbilical cord blood hematopoietic stem cell transplantation. Exp Hematol 28:1197-1205.
3. Moore KA, H Ema and IR Lemischka. (1997). In vitro maintenance of highly purified, transplantable hematopoietic stem cells. Blood 89:4337-4347.
4. McAdams TA, WM Miller and ET Papoutsakis. (1996). Hematopoietic cell culture therapies (part I): cell culture considerations. Trends Biotechnol 14:341-349.
5. Hows JM, BA Bradley, JC Marsh, T Luft, L Coutinho, NG Testa and TM Dexter. (1992). Growth of human umbilical cord blood in long term haemopoietic cultures. Lancet 340:73-76.
6. Sutherland HJ, PM Lansdrop, DH Henkelman, SC Eaves and CJ Eaves. (1990). Functional characterization of individual human hematopoietic stem cells at limiting dilution on supportive marrow stromal layers. Proc Natl Acad Sci USA 87:3584-3588.
7. Prosper F, K Vanoverbeke, D Stroncek and CM Verfaillie. (1997). Primitive long-term culture initialing cells (LTC-ICs) in granulocyte colony-stimulating factor mobilized peripheral blood progenitor cells have similar potential for ex vivo expansion as primitive LTC-ICs in steady state bone marrow. Blood 89:3991-3997.
8. Van Ziffle JA, GM Baerlocher and PM Lansdorp. (2003). Telomere length in subpopulations of human hematopoietic cells. Stem Cells 21:654-660.
9. Zimmermann S, S Glaser, R Ketteler, CF Waller, U Klingmuller and UM Martens. (2004). Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells 22:741-749.
10. Larochelle A, J Vormoor, H Hanenberg, JC Wang, M Bhatia, T Lapidot, T Moritz, B Murdoch, XL Xiao, I Kato, DA Williams and JE Dick. (1996). Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implication for gene therapy. Nature Med 2:1329-1337.
11. + cell count in stem cell grafts. Stem Cells 17:373-376.
12. + cells after ex vivo expansion. Exp Hematol 29:1465-1473.
13. Zandstra PW, E Conneally, AL Petzer, JM Piret and CJ Eaves. (1997). Cytokines manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA 94:4698-4703.
14. Bhatia M, JC Wang, U Kapp, D Bonnet and JE Dick. (1997). Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 94:5320-5325.
15. + cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 16:387-396.
16. Yin AH, S Miraglia, ED Zanjani, G Almeida-Porada, M Ogawa, AG Leary, J Olweus, J Kearney and DW Buck. (1997). AC 133, a novel marker for human hematopoietic stem and progenitor cells. Blood 90:5002-5012.
17. Bhatia M. (2001). AC133 expression in human stem cells. Leukemia 15:1685-1688.
18. Peled A, I Petit, O Kollet, M Magid, T Ponomaryov, T Byk, A Nagler, H Ben-Hur, A Many, L Shultz, O Lider, R Alon, D Zipori and T Lapidot. (1999). Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 283:845-848.
19. + cells induces marked and sustained changes in adhesion receptor and CXCR4 expressions. Stem Cells 21:61-70.
20. Hart C, D Drewel, G Mueller, J Grassinger, M Zaiss, LA Kunz-Schughart, R Andreesen, A Reichle, E Holler and B Hennemann. (2004). Expression and function of homing-essential molecules and enhanced in vivo homing ability of human peripheral blood-derived hematopoietic progenitor cells after stimulation with stem cell factor. Stem Cells 22:580-589.
21. Rubinstein P, C Carrier, A Scaradavou, J Kurtzberg, J Adamson, AR Migliaccio, RL Berkowitz, M Cabbad, NL Dobrila, PE Taylor, RE Rosenfield and CE Stevens. (1998). Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339:1565-1577.
22. Laughlin MJ, M Eapen, P Rubinstein, JE Wagner, MJ Zhang, RE Champlin, C Stevens, JN Barker, RP Gale, HM Lazarus, DI Marks, JJ Van Rood, A Scaradavou and MM Horowitz. (2004). Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med 351:2265-2275.
23. + cells in autologous stem cell transplantation for breast cancer. Blood 87:1687-1691.
24. + cell doses for autologous hematopoietic stem cell transplantation? Bone Marrow Transplant 31:861-864.
25. Yao CL, CH Liu, IM Chu, TB Hsieh and SM Hwang. (2003). Factorial designs combined with the steepest ascent method to optimize serum-free media for ex vivo expansion of human hematopoietic progenitor cells. Enzyme Micro Technol 33:343-352.
26. Ponchio L, L Duma, B Oliviero, N Gibelli, P Pedrazzoli and G Robustelli Della Cuna. (2000). Mitomycin C as alternative to irradiation to inhibit the feeder layer growth in long-term culture assays. Cytother 2:281-286.
27. Bhatia M, D Bonnet, U Kapp, JCY Wang, B Murdoch and JE Dick. (1997). Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med 186:619-624.
28. Lebkowski JS, LR Schain and TB Okarma. (1995). Serum-free culture of hematopoietic stem cells: a review. Stem Cells 13:607-612.
29. Sandstrom CE, WM Miller and TP Papoutsakis. (1994). Review: serum-free media for cultures of primitive and mature hematopoietic cells. Biotechnol Bioeng 43:706-733.
30. + hematopoietic progenitor cells. Biotechnol Bioeng 60:341-347.
31. + cells: comparison of four serum-free media containing bovine or human albumin. Cytother 5:153-160.
32. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci (USA) 90:8707-8711.
33. Nagasawa T, S Hirota, K Tachibana, N Takakura, S Nishikawa, Y Kitamura, N Yoshida, H Kikutani and T Kishimoto. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638.
34. Zou YR, AH Kottmann, M Kuroda, I Taniuchi and DR Littman. (1998). Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 393:595-599.
35. + T cell homeostasis and in vitro HIV-1 susceptibility in transgenic mice expressing T cell line-tropic HIV-1 receptors. J Exp Med 187:1439-1449.
36. Lajtha LG. (1979). Stem cell concepts. Differentiation 14:23-34.
37. Fleming WH, EJ Alpern, N Uchida, K Ikuta, GJ Spangrude and IL Weissman. (1993). Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 122:897-902.
38. Zimmermann S and UM Martens. (2005). Telomere dynamics in hematopoietic stem cells. Curr Mol Med 5: 179-185.
39. Engelhardt M, R Kumar, J Albanell, R Pettengell, W Han and MA Moore. (1997). Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood 90:182-193.
40. Rufer N, TH Brummendorf, S Kolvraa, C Bischoff, K Christensen, L Wadsworth, M Schulzer and PM Lansdorp. (1999). Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 190:157-167.
41. Vaziri H, W Dragowska, RC Allsopp, TE Thomas, CB Harley and PM Lansdorp, (1994). Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91:9857-9860.